Related Experiment Video

Updated: Jul 16, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.6K

Personalized neoantigen cancer vaccines: An analysis of the clinical and commercial potential of ongoing development

Maurice Perrinjaquet1, C Richard Schlegel2

  • 1EY-Parthenon, Basel, Switzerland.

Drug Discovery Today
|September 20, 2023
PubMed

Insights

Neoantigen cancer vaccines offer personalized cancer therapy. This paper reviews their development and discusses commercialization challenges for these promising immuno-oncology treatments.

Area of Science:

  • Oncology
  • Immunotherapy
  • Vaccinology

Background:

  • Neoantigen cancer vaccines represent a personalized approach to cancer therapy, targeting patient-specific tumor antigens.
  • Several biotechnology companies are actively developing these next-generation immuno-oncology treatments.
  • Limited information is available regarding the commercial viability and regulatory hurdles for neoantigen vaccines.

Purpose of the Study:

  • To provide an overview of current neoantigen cancer vaccine development programs.
  • To discuss the anticipated commercial landscape for these therapies post-regulatory approval.

Main Methods:

  • Literature review of ongoing neoantigen cancer vaccine development.
  • Analysis of the commercial environment and potential challenges for market entry.

Main Results:

  • Overview of key players and developmental stages in neoantigen vaccine research.
  • Identification of potential commercialization barriers, including regulatory pathways and market access.

Conclusions:

  • Neoantigen cancer vaccines hold significant promise for personalized cancer treatment.
  • Understanding the commercial and regulatory landscape is crucial for the successful launch of these innovative therapies.
Keywords:
immun-oncologymRNA vaccinespersonalized cancer vaccines

More Related Videos

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.3K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.0K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
399
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381